Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Grzeszczak

Showing results (1-10 of 328) with videos related to

Pageof 33
Sort By:
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|December 19, 1983
[Use of opiate antagonists in the treatment of shock. Description of a case of shock treated with naloxone]W Grzeszczak
Postepy Higieny I Medycyny Doswiadczalnej|September 1, 1980
[Intestinal adaptation]W Grzeszczak
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|August 1, 1998
[Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes]W Grzeszczak
Polskie Archiwum Medycyny Wewnetrznej|November 5, 2002
[Genetics of late complications of diabetes--importance of gene candidates in development of diabetic nephropathy]W Grzeszczak
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|April 4, 2002
[The effect of improved glycemic control on quality of life in patients with type I and type II diabetes]W Grzeszczak
Przeglad Lekarski|January 1, 1985
[Recurrent acute renal failure--a case report]W Grzeszczak
Polskie Archiwum Medycyny Wewnetrznej|July 1, 1995
[How to prevent diabetic nephropathy or to delay its development]W Grzeszczak
Polskie Archiwum Medycyny Wewnetrznej|April 1, 1993
[Lipid disturbances in kidney transplant patients]W Grzeszczak
Przeglad Lekarski|April 11, 2001
[Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)]W Grzeszczak
Przeglad Lekarski|April 11, 2001
[Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes]W Grzeszczak
Pageof 33

Showing results (1-10 of 328) with videos related to

Sort By:
Pageof 33
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|December 19, 1983
[Use of opiate antagonists in the treatment of shock. Description of a case of shock treated with naloxone]W Grzeszczak
Postepy Higieny I Medycyny Doswiadczalnej|September 1, 1980
[Intestinal adaptation]W Grzeszczak
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|August 1, 1998
[Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes]W Grzeszczak
Polskie Archiwum Medycyny Wewnetrznej|November 5, 2002
[Genetics of late complications of diabetes--importance of gene candidates in development of diabetic nephropathy]W Grzeszczak
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|April 4, 2002
[The effect of improved glycemic control on quality of life in patients with type I and type II diabetes]W Grzeszczak
Przeglad Lekarski|January 1, 1985
[Recurrent acute renal failure--a case report]W Grzeszczak
Polskie Archiwum Medycyny Wewnetrznej|July 1, 1995
[How to prevent diabetic nephropathy or to delay its development]W Grzeszczak
Polskie Archiwum Medycyny Wewnetrznej|April 1, 1993
[Lipid disturbances in kidney transplant patients]W Grzeszczak
Przeglad Lekarski|April 11, 2001
[Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)]W Grzeszczak
Przeglad Lekarski|April 11, 2001
[Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes]W Grzeszczak
Pageof 33